Participants
The study was conducted at the division of pediatric oncology, department of pediatrics and adolescent medicine, Aarhus University Hospital. From January 2010 to July 2011. All children aged 0 to 17 years, who were treated for any type of neoplastic diseases and had a planned removal of a CVC due to treatment termination, were eligible. Excluding criteria were known allergy to band aid or fusidic acid.
All parents and children received oral and written study information. Both custody authorities provided a written consent. The clinical trial nr. NCT01113125 was approved by the Regional Committee on Health Research Ethics, and performed according to the Declaration of Helsinki.